Pancreatic Cancer Research

ResearcherCapital Medical UniversityActive in the last 2 years

Hongyi Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2515-6912; OpenAlex author ID A5100659994. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Exploring the survival benefits of surgical treatment for pancreatic adenocarcinoma using the DeepSurv neural network model. Last author DOI 10.1080/24699322.2025.2556334↗
  2. Association between CLPTM1L-TERT rs401681 polymorphism and risk of pancreatic cancer: a meta-analysis. Last author DOI 10.1007/s10238-014-0316-3↗
  3. Association between CLPTM1L-TERT rs401681 polymorphism and pancreatic cancer risk among Chinese Han population. Last author DOI 10.1007/s13277-014-1711-9↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xin Wang · 1 shared paper, 2025 · strength 0.30
  2. Chengli Liu · 2 shared papers, 2014–2015 · strength 0.11
  3. Cheng Wang · 1 shared paper, 2015 · strength 0.06
  4. Yingjie Wang · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.